Murchinson Criticizes the Nano Dimension Board of Directors’ Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics
Go back to Murchinson Criticizes the Nano Dimension Board of Directors’ Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics| (NASDAQ: NNDM) | Delayed: 1.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.62 | 52 Week High | $9.40 | |||
| Open | $1.62 | 52 Week Low | $6.20 | |||
| Day High | $1.62 | P/E | N/A | |||
| Day Low | $1.62 | EPS | $0.00 | |||
| Volume | 673 | |||||
